Patents by Inventor Hiroyuki Odaka

Hiroyuki Odaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent for treating high-risk impaired glucose tolerance
    Patent number: 6200958
    Abstract: The present invention discloses an &agr;-glucosidase inhibitor for prevention of transition from high-risk IGT to diabetes mellitus, for prophylaxis of diabetes mellitus, as well as for treating high-risk IGT.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: March 13, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hiroyuki Odaka, Ichiro Nakaoka, Yoshiharu Suzuki
  • Oxazole derivatives, their production and use
    Patent number: 6177452
    Abstract: A novel compound of the formula: wherein R1 is a halogen atom, an optionally substituted heterocyclic, hydroxy, thiol or amino group; A is an optionally substituted acyl group, an optionally substituted heterocyclic group, an optionally substituted hydroxy group, or an optionally esterified or amidated carboxy group; B is an optionally substituted aromatic group; Y is a divalent aliphatic hydrocarbon group, or a salt thereof, which have an excellent insulin secertion-promoting and blood sugar-depressing effect, and useful in agents for diabetes.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: January 23, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Yu Momose, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6174904
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: January 16, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6172090
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: January 9, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6172089
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: January 9, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6169100
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: January 2, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6169099
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: January 2, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6166043
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: December 26, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6166042
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: December 26, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6156773
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: December 5, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6150384
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: November 21, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6150383
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: November 21, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6133293
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: October 17, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6133295
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: October 17, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6121294
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: September 19, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6121295
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: September 19, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6103742
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: August 15, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6080765
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: June 27, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 5965584
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: October 12, 1999
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Thiazolidinedione derivatives, their production and use
    Patent number: 5965589
    Abstract: A 2,4-thiazolidinedione derivative of the formula (I): ##STR1## wherein R is an optionally substituted hydrocarbon group or heterocyclic group which may be attached through a hydrocarbon chain; n is 0 or 1; X is CH or N; Y is a bivalent hydrocarbon group; R.sup.1 and R.sup.2 are the same or different and are a hydrogen atom, a halogen atom, an optionally substituted hydroxyl group or an optionally substituted hydrocarbon group, and either R.sup.1 or R.sup.2 and a part of Y may be linked together to form a ring; and L and M are a hydrogen atom, or L and M are linked together to form a bond; or a salt thereof. A pharmaceutical composition comprising the compound (I) and a process for producing the compound (I) are also provided.
    Type: Grant
    Filed: October 5, 1995
    Date of Patent: October 12, 1999
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Takashi Sohda, Hiroyuki Odaka, Yu Momose